HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,619 | 0.0% | 83,809 | 0.0% | 0.04% | 0.0% |
| Q2 2023 | $8,619 | -46.8% | 83,809 | -43.5% | 0.04% | -56.1% |
| Q1 2023 | $16,192 | -29.4% | 148,368 | -60.0% | 0.08% | -31.7% |
| Q4 2022 | $22,951 | -99.9% | 370,840 | 0.0% | 0.12% | 0.0% |
| Q3 2022 | $22,951,000 | -19.9% | 370,840 | +3.2% | 0.12% | -16.7% |
| Q2 2022 | $28,650,000 | -29.3% | 359,205 | -6.7% | 0.14% | -4.0% |
| Q1 2022 | $40,523,000 | +37.8% | 385,166 | +41.2% | 0.15% | +63.0% |
| Q4 2021 | $29,405,000 | -5.2% | 272,874 | -3.7% | 0.09% | -19.3% |
| Q3 2021 | $31,033,000 | +1.7% | 283,305 | -13.1% | 0.11% | +107.3% |
| Q2 2021 | $30,526,000 | -5.4% | 325,992 | -7.0% | 0.06% | -15.4% |
| Q1 2021 | $32,258,000 | -58.8% | 350,482 | +80.0% | 0.06% | +97.0% |
| Q4 2020 | $78,360,000 | +1073.8% | 194,766 | +126.6% | 0.03% | +65.0% |
| Q3 2020 | $6,676,000 | – | 85,952 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |